Research Article
Comprehensive Analysis of DNA Methylation and Transcriptome to Identify PD-1-Negative Prognostic Methylated Signature in Endometrial Carcinoma
Table 2
13 DMDGs and compounds that can interact with them.
| Gene | GeneType | DrugCount | Drug example |
| BST1 | HyperDown | 5 | Etheno-NAD, nicotinamide, adenosine 5-[gamma-thio] triphosphate | CDO1 | HyperDown | 2 | Cysteine, NADH | CLEC14A | HyperDown | 1 | Resveratrol | COX7A1 | HyperDown | 2 | Cholic acid, N-formylmethionine | DDR2 | HyperDown | 2 | Regorafenib, fostamatinib | FCER1A | HypoDown | 3 | Omalizumab, benzylpenicilloyl polylysine, TNX-901 | GSTM5 | HyperDown | 2 | Glutathione, glutathione disulfide | HBB | HypoDown | 19 | Iron dextran, zinc, 4-carboxycinnamic acid | RIC3 | HyperDown | 1 | Theophylline | SERPINB5 | HypoUp | 1 | S,S-(2-Hydroxyethyl)thiocysteine | SPARC | HyperDown | 3 | Calcium citrate, calcium phosphate, calcium phosphate dihydrate | VCAM1 | HyperDown | 4 | Ethanol, carvedilol, succinobucol | XDH | HypoUp | 9 | Allopurinol, levocarnitine, topiroxostat |
|
|